Skip to content

Moxibustion intervention for pain in rheumatoid arthritis

The mechanism of moxibustion intervention for treating rheumatoid arthritis pain and its pain management

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020343
Enrollment
Unknown
Registered
2018-12-25
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

Moxibustion treatment group:Moxibustion, Zusanli, Shengyuxue, Ashixue
Control group:No

Sponsors

The Second Affiliated Hospital of Nantong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. according with the 1987 ACR diagnosis standards; 2. male or female aged 18 to 60 years old; 3. subject knows the informed consent, and signs voluntarily his name on the informed paper.

Exclusion criteria

Exclusion criteria: 1. Joining other clinical study within four weeks; 2. Moxibustion has an adverse reaction or is unwilling to receive moxibustion; 3. In accordance with the inclusion criteria, the treatment is not prescribed, and it is impossible to judge whether the efficacy or the incomplete data affect the efficacy or safety judgment; 4. With other serious diseases; 5. Pregnant women or breast-feeding women; 6. With mental illness.

Design outcomes

Primary

MeasureTime frame
VAS;

Countries

China

Contacts

Public ContactShen Biyu

The Second Affiliated Hospital of Nantong University

shenbiyu@126.com+86 13862937317

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026